Journal Article
Police Legitimacy and Disrupting Overt Drug Markets
Jun 30, 2017
Overt drug markets are often associated with violence and property crime, as well as lower quality of life for nearby residents. This process evaluation describes how well seven jurisdictions adhered to a Bureau of Justice Assistance strategy to reduce overt drug markets, as well as the barriers they encountered and the lessons learned from their experiences.
A Process and Fidelity Evaluation of Seven Sites
Does not include Appendix G.
Format | File Size | Notes |
---|---|---|
PDF file | 0.8 MB | Use Adobe Acrobat Reader version 10 or higher for the best experience. |
Format | File Size | Notes |
---|---|---|
PDF file | 0.2 MB | Use Adobe Acrobat Reader version 10 or higher for the best experience. |
Overt drug markets are often associated with violence and property crime, as well as lower quality of life for nearby residents. Despite the considerable strain these markets can place on communities, efforts to close them can disrupt the delicate relationship between those who live in these communities and the criminal justice agencies charged with protecting them. In 2010, the Bureau of Justice Assistance (BJA) funded Michigan State University (MSU) to train a cohort of seven jurisdictions to implement a community-based strategy that uses focused deterrence, community engagement, and incapacitation to reduce the crime and disorder associated with overt drug markets. The strategy was inspired by the High Point Drug Market Intervention and RAND was selected by the National Institute of Justice to evaluate these efforts. This process evaluation describes how well the seven sites adhered to the BJA model they were exposed to during the trainings, the barriers they encountered, and lessons learned from their experiences.
Chapter One
Introduction
Chapter Two
Motivation for and Theoretical Underpinnings of the DMI
Chapter Three
Approach Used in this Process Evaluation
Chapter Four
Process Evaluation, Phase I: Planning for the Intervention
Chapter Five
Process Evaluation, Phase II: Targeting the Drug Market
Chapter Six
Process Evaluation, Phase III: Working with the Community
Chapter Seven
Process Evaluation, Phase IV: Preparing for the Call-In
Chapter Eight
Process Evaluation, Phase V: After the Call-In
Chapter Nine
Discussion of Process Evaluation Findings and Implementation Lessons Learned
Appendix A
Ratio of A-Listers to B-Listers
Appendix B
A-Lister Sentences
Appendix C
Process Evaluation Forms
Appendix D
Semistructured Interview with Team Members
Appendix E
Roanoke Redacted Offender Notification Letter
Appendix F
Roanoke Life College Agenda
The research reported here was conducted in the RAND Justice Policy Program, a part of RAND Justice, Infrastructure, and Environment.
This report is part of the RAND Corporation Research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.